Swiss biotech Idorsia has claimed FDA approval for its first product – insomnia treatment Quviviq – setting up a market challenge to class rivals from Merck & Co and Eisai. The US regulator ...

"For decades, menopause has been overlooked in both clinical research and health care policy, largely because it affects ...